Authors
Chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida.
Shayla Bergmann, MD, is a clinical professor in pediatric hematology at the Medical University of South Carolina.
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
3
Social Factors Shape Diabetes, Dementia Risk Across Populations
4
Bridging Science and Reality in Diabetes Care
5
